- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.33 Å
- Oligo State
- monomer
- Ligands
- 1 x QK8: ethyl (4~{S})-4-[4-[(1-methylcyclobutyl)carbamoyl]piperidin-1-yl]azepane-1-carboxylate(Non-covalent)
- 11 x OLA: OLEIC ACID(Non-covalent)
OLA.2: 7 residues within 4Å:- Chain A: I.382, T.386, I.390, V.394, C.401, P.403, L.406
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.382, A:I.390, A:I.390, A:V.394
OLA.3: 7 residues within 4Å:- Chain A: Q.38, Y.43, F.46, C.50, I.54, L.124, W.131
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:Q.38, A:Y.43, A:F.46, A:I.54, A:L.124, A:W.131
OLA.4: 8 residues within 4Å:- Chain A: I.9, V.12, L.16, E.408, L.409, W.412, L.413
- Ligands: OLA.11
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:I.9, A:I.9, A:V.12, A:L.16, A:W.412, A:L.413, A:L.413
OLA.5: 9 residues within 4Å:- Chain A: M.95, L.99, F.102, F.106, Y.114, R.122, M.126, L.129, A.130
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.99, A:F.102, A:F.106, A:L.129, A:A.130
- Salt bridges: A:R.122
OLA.6: 7 residues within 4Å:- Chain A: A.57, F.58, N.61, L.62, V.65, M.69, L.74
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:A.57, A:F.58, A:F.58, A:N.61, A:V.65, A:L.74, A:L.74
OLA.7: 9 residues within 4Å:- Chain A: E.210, I.228, G.229, D.269, V.302, F.303, Q.304, G.306, E.307
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.303, A:E.307
- Hydrogen bonds: A:D.269
OLA.11: 5 residues within 4Å:- Chain A: V.12, T.405, L.409
- Ligands: OLA.4, OLA.12
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.12, A:T.405, A:L.409
- Hydrogen bonds: A:T.405
OLA.12: 3 residues within 4Å:- Chain A: E.5, V.12
- Ligands: OLA.11
No protein-ligand interaction detected (PLIP)OLA.13: 6 residues within 4Å:- Chain A: L.74, G.75, A.76, L.77, A.78, A.156
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.77
- Hydrogen bonds: A:A.76
- Water bridges: A:G.75, A:R.152
OLA.14: 8 residues within 4Å:- Chain A: A.19, G.23, L.26, M.423, A.426, L.427, R.433, F.436
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:A.19, A:L.26, A:M.423, A:A.426, A:L.427, A:F.436
- Hydrogen bonds: A:L.427
OLA.15: 8 residues within 4Å:- Chain A: L.137, P.140, A.141, F.144, L.148, F.163, T.173, T.177
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.137, A:L.137, A:P.140, A:A.141, A:F.144, A:L.148, A:F.163, A:T.173, A:T.177
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 3 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.9: 6 residues within 4Å:- Chain A: G.312, F.313, T.314, N.315, S.316, N.331
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.315, A:N.315, A:S.316, A:S.316
PO4.10: 5 residues within 4Å:- Chain A: Q.340, T.341, P.342, N.343, R.344
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.343, A:N.343, A:R.344
- Water bridges: A:R.347, A:R.347, A:R.347
PO4.16: 3 residues within 4Å:- Chain A: R.104, R.115, K.264
6 PLIP interactions:6 interactions with chain A- Water bridges: A:T.39, A:R.118, A:R.118
- Salt bridges: A:R.104, A:R.115, A:K.264
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, A.J.H. et al., From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease. Cell (2021)
- Release Date
- 2021-10-06
- Peptides
- Muscarinic acetylcholine receptor M1,Endolysin,Muscarinic acetylcholine receptor M1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.33 Å
- Oligo State
- monomer
- Ligands
- 1 x QK8: ethyl (4~{S})-4-[4-[(1-methylcyclobutyl)carbamoyl]piperidin-1-yl]azepane-1-carboxylate(Non-covalent)
- 11 x OLA: OLEIC ACID(Non-covalent)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 3 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, A.J.H. et al., From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease. Cell (2021)
- Release Date
- 2021-10-06
- Peptides
- Muscarinic acetylcholine receptor M1,Endolysin,Muscarinic acetylcholine receptor M1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.